Enovis Corp. (ENOV)
26.51
+0.19
(+0.72%)
USD |
NYSE |
Apr 20, 09:52
Enovis SG&A Expense (Quarterly) : 270.44M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 169.27M |
| Globus Medical, Inc. | 318.48M |
| Abbott Laboratories | 3.74B |
| Accuray, Inc. | 18.91M |
| Plus Therapeutics, Inc. | 4.168M |